These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9932635)

  • 21. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].
    Dziura M; Wasikowa R
    Pediatr Endocrinol Diabetes Metab; 2008; 14(1):61-3. PubMed ID: 18577350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-induced lipodystrophy and interest of insulin injection ports.
    Ben Abdelkrim A; Fathallah N; Omri M; Hasni Y; Khaldi S; Kacem M; Chaieb M; Ben Salem C; Maaroufi A; Ach K
    Therapie; 2019 Dec; 74(6):680-682. PubMed ID: 31088690
    [No Abstract]   [Full Text] [Related]  

  • 25. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe lipoatrophy with human insulin: successfully treated by CSII.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099
    [No Abstract]   [Full Text] [Related]  

  • 27. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of suppurative granuloma induced by insulin injection.
    Tanizaki H; Matsumura Y; Tokura Y; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2010 Sep; 90(5):540-1. PubMed ID: 20814643
    [No Abstract]   [Full Text] [Related]  

  • 29. Human insulin analog--induced lipoatrophy.
    Lopez X; Castells M; Ricker A; Velazquez EF; Mun E; Goldfine AB
    Diabetes Care; 2008 Mar; 31(3):442-4. PubMed ID: 18162498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
    Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
    J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.
    Chantelau EA; Prätor R; Prätor J
    J Med Case Rep; 2014 Jun; 8():223. PubMed ID: 24961832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus.
    Mu L; Goldman JM
    Endocr Pract; 2000; 6(2):151-2. PubMed ID: 11421532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
    Kordonouri O; Biester T; Weidemann J; Ott H; Remus K; Grothaus J; Pisarek N; Hartmann R; Adolph K; Lange K; Danne T
    Pediatr Diabetes; 2020 Nov; 21(7):1285-1291. PubMed ID: 32738019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoatrophy at insulin injection site.
    Velayutham P; Shriraam M; Bhadada S; Bhansali A
    J Assoc Physicians India; 2008 May; 56():335. PubMed ID: 18700641
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cromolyn sodium for insulin-induced lipoatrophy: old drug, new use.
    Phua EJ; Lopez X; Ramus J; Goldfine AB
    Diabetes Care; 2013 Dec; 36(12):e204-5. PubMed ID: 24265375
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipoatrophy in children with type 1 diabetes: an increasing incidence?
    Kordonouri O; Biester T; Schnell K; Hartmann R; Tsioli C; Fath M; Datz N; Danne T
    J Diabetes Sci Technol; 2015 Mar; 9(2):206-8. PubMed ID: 25411060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoatrophy induced by subcutaneous insulin infusion: ultrastructural analysis and gene expression profiling.
    Milan G; Murano I; Costa S; Pianta A; Tiengo C; Zulato E; Centobene C; Bruttomesso D; Cinti S; Vettor R
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3126-32. PubMed ID: 20484470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe lipoatrophy with insulin in type 1 diabetes.
    Ma X; Lv H; Li Q; Shen J
    J Dermatol; 2012 Jun; 39(6):578-9. PubMed ID: 22097884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.